Carcinoembryonic Antigen (CEA)
Carcinoembryonic antigen is a watch-post, not a search party. Its real job starts after a cancer is found: tracking whether the number creeps back up between scans.
Part of the Tumor Markers — see all 11 values together, including Alpha-Fetoprotein, Beta-hCG, Cancer Antigen 125.
A CEA result is almost meaningless until you answer a different question first: why was the test ordered? The same number, say a 6, tells two opposite stories. In a healthy non-smoker who got it bundled into a curiosity panel, a 6 is usually noise worth rechecking. In someone six months past colon surgery whose last three readings sat near 2, a 6 is the number their oncologist has been watching for. Carcinoembryonic antigen is one of the few blood tests where the value alone is not enough to read it.
CEA is a protein that fetal gut tissue makes in abundance and that healthy adults make only a little of. Some cancers, colorectal cancer most reliably, switch the protein back on, and it spills into the blood. The instinct is to treat that as a cancer detector. It is not built for that job. Picture a trail camera staked at one fixed spot on a path: it is hopeless for finding an animal you have never seen, because it only watches the few feet in front of the lens. What it does brilliantly is record whether something that passed through once comes back. CEA works the same way. Pointed at the open question of "do I have cancer," it sees almost nothing useful. Pointed at a known cancer over time, it does real work.
That is why this number lives mostly after a diagnosis, not before one. Most of what follows is about reading the camera's footage rather than its single frames.
How the number is usually read
ng/mL (µg/L)The StatPearls reference puts the usual non-smoker ceiling at about 3.0 ng/mL. ng/mL and µg/L are the same value with two labels, so a 3 in either unit is the same result.
Smoking is one of the most common benign reasons CEA runs higher, so many labs print a separate ceiling near 5 for smokers. A 4 here is unremarkable.
In someone never diagnosed with cancer, a number a little above the ceiling is far more often smoking, liver or bowel inflammation, or a passing illness than a tumor. The move is to recheck, not to panic.
A CEA that was low and climbs across successive draws is the signal surveillance exists to catch. It prompts imaging, never a diagnosis on its own.
The reference ceiling looks like the important line, and for this test it mostly is not. A single value sits against population averages that lump smokers, people with fatty liver, and people fighting a cold in with everyone else. The line that actually carries information is the one drawn between your own readings over months. A flat CEA of 4 reassures more than a one-off 4 ever could, and a CEA that walks from 1 to 2 to 4 over three visits says something a 4 in isolation cannot.
What does a high CEA mean?
High CEA means the protein is leaking into the blood faster than usual, and it does not say from where. In a person without a cancer diagnosis, the boring explanations dominate, and most of them are not cancer at all.
What can raise CEA
-
Smoking
The most common benign driver, and the reason smokers get a higher reference ceiling. The effect is real enough that some test instructions ask you to pause beforehand.
-
Bowel and stomach inflammation
Inflammatory bowel disease, peptic ulcers, and other gut inflammation can nudge it up without any cancer involved.
-
Other cancers
Beyond colorectal, cancers of the pancreas, stomach, lung, breast, and ovary can also raise CEA, which is part of why a high value never names its own source.
Because the protein has so many sources, the test cannot tell colon from lung from a stressed liver. That non-specificity is exactly what makes it a poor first-line search tool and a good follow-along tool once the target is already known. Where CEA tracks epithelial tumors, NSE covers the neuroendocrine side, though it is especially prone to false elevation from a hemolyzed draw. Where CEA tracks several common epithelial cancers, chromogranin A is the marker reached for in suspected neuroendocrine tumors, and unlike CEA it can be driven high purely by a proton pump inhibitor.
Why CEA is the wrong test for "do I have cancer?"
This is the heart of it. CEA fails as a screening test in both directions at once. MedlinePlus states directly that CEA tests are not used to screen for or diagnose cancer, and the StatPearls review attributes that to low sensitivity and specificity. In plainer terms: a normal CEA never clears you, because many tumors, including a meaningful share of colorectal cancers, secrete little or none of it. And a raised CEA rarely convicts anyone, because smoking and benign inflammation crowd the same range.
So a CEA ordered out of general worry, with no diagnosis behind it, lands in the worst spot the test offers: too leaky to reassure, too noisy to alarm. If a result like that comes back mildly high and you have no cancer history, the genuinely useful next step is a recheck and a look at the benign causes, framed with your doctor, rather than a spiral over one number. The companion idea, that a single reading is weak but a direction is strong, is the same one that runs through how lab trends are read over time.
Where CEA actually proves useful
After a colorectal cancer is diagnosed and treated, the camera finally has something to watch. Three roles are standard, and all three read change rather than an absolute value.
First, a baseline. A CEA drawn before treatment sets the personal reference everything afterward is measured against. Second, response. MedlinePlus notes that a CEA falling over time after treatment often means the treatment is working, and a level that stays high may mean it is not. Third, surveillance for recurrence. A CEA that drops and then climbs across follow-up tests is the early-warning pattern doctors watch for when checking whether the cancer has come back. In breast cancer monitoring, CEA is sometimes tracked alongside CA 27-29, with both read as a trend across serial draws rather than as any single value.
How a rising CEA is handled after treatment
-
1
It is the trend, not the single number
One isolated reading is rarely acted on. Clinicians look for a sustained climb across serial draws, which is why follow-up CEA is scheduled at intervals rather than once.
-
2
The schedule is built around catching change early
For monitoring after colorectal surgery, the StatPearls review describes measuring CEA about every three months for the first two years, then every six months out to five years. Your oncologist sets the exact cadence.
-
3
A rise triggers imaging, not a diagnosis
A confirmed upward trend prompts scans and a fuller workup to find what changed. CEA flags the question; imaging and tissue answer it.
-
4
A flat or normal CEA does not close the case
Because some tumors do not shed CEA, surveillance pairs it with colonoscopy and imaging. The number is one input, never the whole picture.
One honest limitation runs through all of this: in people who smoke, the test gets noisier in exactly the way that matters. Smoking does not just raise the baseline, it widens the band of normal scatter the trend has to rise above to be believed, so doctors often lean harder on imaging in active smokers.
CEA among the tumor markers
CEA is one entry in a small family of proteins the body makes more of in certain cancers, grouped on lab reports as tumor markers. Each is tied to particular cancers and carries the same caveat: they monitor and prognosticate far better than they screen. In gastrointestinal cancers, CEA is often read next to CA 19-9, which leans toward pancreatic and biliary disease; AFP belongs to liver and germ-cell tumors, and CA 125 to ovarian. In breast cancer follow-up, CEA is often tracked beside CA 15-3, with both read for their trend across draws rather than any single value. The guide to reading tumor markers explains why none of them should be read as a yes-or-no cancer test, and why the question behind the order changes everything about the answer.
Sources
- CEA Test — MedlinePlus, National Library of Medicine
- Tumor Markers in Common Use — National Cancer Institute
Written and reviewed by BloodSight Editorial Team · Last updated
See your Carcinoembryonic Antigen on one timeline.
BloodSight calibrates the reference range to your sex, age, and lab — and shows every value across every visit.
In your personal range
Normal ranges
| Group | Range | Unit |
|---|---|---|
| Adult Non-smoker | 0–3 | ng/mL |
| Adult Smoker | 0–5 | ng/mL |
Reference ranges may vary by laboratory and individual factors.
Carcinoembryonic Antigen — Common Questions
Is a CEA of 7 or 10 cancer?
Why is CEA not used to screen for cancer?
Do smokers have higher CEA levels?
What does a rising CEA after colon cancer surgery mean?
Can you have colon cancer with a normal CEA?
Disclaimer
This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Reference ranges may vary by laboratory. Always discuss your results with a qualified healthcare professional.
Related Tests
CA 19-9 is the main blood marker doctors track in pancreatic and bile-duct cancers. Its strangest quirk: a sizable minority of people are simply built not to produce it at all.
AFP is read as a cancer marker, but a liver healing from hepatitis or cirrhosis raises it too. Here is how to read the number without panic.
The blood test named for cancer trips for menstruation, pregnancy and fibroids. Here is what a number over 35 actually tells you, and the screening question it can't answer.
ALT is the enzyme liver cells spill when they are injured. The blood level counts that damage rather than how well the liver works, which is why a hard workout or a new pill can lift it.
GGT is the most sensitive of the liver enzymes and one of the least specific. A high reading says the liver or bile ducts, almost certainly. It rarely says which problem.
CRP confirms inflammation is somewhere in the body. It almost never says what is inflamed or where, and that limit is exactly why it stays one of the most-ordered blood tests.
ALP comes from two places at once: the liver and bile ducts, and growing or remodeling bone. A high reading rarely says which, and a child's level runs two to three times an adult's by design.
One CA 15-3 reading rarely settles anything. Built for serial monitoring, the test speaks through its trajectory, not its latest figure.
Neuron-specific enolase tracks small cell lung cancer and neuroblastoma — but it also leaks out of red cells, so a roughly handled tube can fake a high result.
CA 27-29 is read like a river gauge after a storm. A single waterline tells you almost nothing; whether the line is climbing or receding is the whole message.
Chromogranin A is a neuroendocrine tumor marker, yet one of the commonest reasons it reads high is a pill millions take for reflux. Here is why, and what to do before the draw.